Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions

Localization of dopamine (D1‐, D2‐like, and D4) and ionotropic glutamate (NMDA, AMPA, and KA) receptor subtypes within the striatolimbic forebrain remains incomplete, but basic to understanding the functional organization of this important brain region. We found that frontal cortical ablation supported colocalization of D4 and NMDA receptors on corticostriatal afferents to caudate‐putamen and nucleus accumbens in rat forebrain. Local injection of kainic acid into caudate‐putamen, nucleus accumbens, or hippocampus produced massive local postsynaptic losses of D1‐ and D2‐like, as well as NMDA, AMPA, and KA receptors, and kainic acid ablation of hippocampal–striatal projections indicated the selective expression of presynaptic NMDA and KA autoreceptors. Degeneration of nigrostriatal dopamine projections with 6‐hydroxydopamine showed that all three glutamatergic subtypes exist as heteroceptors on nigrostriatal dopaminergic terminals. Our findings suggest common interactions between excitatory glutamatergic and inhibitory dopaminergic receptors in rat forebrain. Further localization of these receptor subtypes in striatolimbic forebrain should help to clarify their contributions to the pathophysiology of neuropsychiatric disorders and their treatment. J. Neurosci. Res. 55:401–410, 1999. © 1999 Wiley‐Liss, Inc.

[1]  S. Snyder,et al.  Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.

[2]  M. Kuhar,et al.  Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: Effects of lesions , 1979 .

[3]  R. Baldessarini,et al.  Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. , 1979, International review of neurobiology.

[4]  J. Coyle,et al.  Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum , 1979, Journal of neuroscience research.

[5]  J. Coyle,et al.  Characterization of specific, high-affinity binding sites for l-[3H]glutamic acid in rat brain membranes , 1980, Brain Research.

[6]  H. Mclennan,et al.  The effect of decortication on the excitatory amino acid sensitivity of striatal neurones , 1980, Neuroscience Letters.

[7]  P. Jenner,et al.  Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D‐2 receptors exist post‐synaptically on corticostriate afferents and striatal neurons , 1981, The Journal of pharmacy and pharmacology.

[8]  A. Kelley,et al.  The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde and retrograde-horseradish peroxidase study , 1982, Neuroscience.

[9]  N. Sharif,et al.  Striatal glutamatergic function: Modifications following specific lesions , 1982, Brain Research.

[10]  J. Penney,et al.  Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  G. Wooten,et al.  Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography , 1986, Nature.

[12]  M. Errami,et al.  Development of a micromethod to study the Na+-independentl-[3H]glutamic acid binding to rat striatal membranes. II. Effects of selective striatal lesions and deafferentations , 1986, Brain Research.

[13]  T. Dawson,et al.  Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride. , 1987, European journal of pharmacology.

[14]  J. Joyce,et al.  Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents , 1987, Neuroscience.

[15]  A. Nieoullon,et al.  α‐[3H]Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding to Rat Striatal Membranes: Effects of Selective Brain Lesions , 1988, Journal of neurochemistry.

[16]  C. Cotman,et al.  The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. , 1989, Annual review of pharmacology and toxicology.

[17]  A. Young,et al.  Synaptic localization of striatal NMDA, quisqualate and kainate receptors , 1989, Neuroscience Letters.

[18]  D. Jeste,et al.  Hippocampal pathologic findings in schizophrenia. A morphometric study. , 1989, Archives of general psychiatry.

[19]  A. Nieoullon,et al.  Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding , 1990, Journal of neurochemistry.

[20]  R. Kerwin,et al.  Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem , 1990, Neuroscience.

[21]  B. Pakkenberg,et al.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.

[22]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[23]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[24]  R. Roth,et al.  Autoreceptor Regulation of Dopamine Synthesis , 1990, Annals of the New York Academy of Sciences.

[25]  G. Fagg,et al.  Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. , 1990, Trends in pharmacological sciences.

[26]  R. Baldessarini,et al.  Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. , 1990, Molecular pharmacology.

[27]  J. Desce,et al.  Glutamate Receptors of a Quisqualate‐Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo , 1990, The European journal of neuroscience.

[28]  S. Young,et al.  Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.

[29]  J. Desce,et al.  Glutamatergic Control of Dopamine Release in the Rat Striatum: Evidence for Presynaptic N‐Methyl‐D‐Aspartate Receptors on Dopaminergic Nerve Terminals , 1991, Journal of neurochemistry.

[30]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[31]  Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine. , 1991, Biochemical pharmacology.

[32]  S. Young,et al.  Terminal excitability of the corticostrial pathway. I. Regulation by dopamine receptor stimulation , 1991, Brain Research.

[33]  S. Nakanishi,et al.  A family of metabotropic glutamate receptors , 1992, Neuron.

[34]  D. Surmeier,et al.  Dopamine receptor subtypes colocalize in rat striatonigral neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Yamamoto,et al.  Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis , 1992, Journal of neurochemistry.

[36]  J. Penney,et al.  Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study , 1992, Neuroscience.

[37]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization , 1992, Trends in Neurosciences.

[38]  R. Albin,et al.  Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons , 1992, Brain Research.

[39]  D. Sibley,et al.  D2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera , 1993, Brain Research.

[40]  P. Calabresi,et al.  Chemical modulation of synaptic transmission in the striatum. , 1993, Progress in brain research.

[41]  C. Cotman,et al.  Excitatory amino acid receptors in schizophrenia. , 1993, Schizophrenia bulletin.

[42]  C. Cotman,et al.  Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. , 1993, Neuroreport.

[43]  D. Surmeier,et al.  Are neostriatal dopamine receptors co-localized? , 1993, Trends in Neurosciences.

[44]  E. French,et al.  Electrophysiological evidence for the existence of NMDA and non‐NMDA receptors on rat ventral tegmental dopamine neurons , 1993, Synapse.

[45]  R. Petralia,et al.  Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies , 1994, The Journal of comparative neurology.

[46]  D. Sibley,et al.  Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes , 1994, Brain Research.

[47]  J. Penney,et al.  Glutamate receptor expression in rat striatum: Effect of deafferentation , 1994, Brain Research.

[48]  J. Penney,et al.  Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions , 1994, Brain Research.

[49]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[50]  F. Benes.  Is There a Neuroanatomic Basis for Schizophrenia? An Old Question Revisited , 1995 .

[51]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[52]  L. Meltzer,et al.  Evidence for N-methyl-d-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-d-aspartate receptors , 1995, Neuroscience.

[53]  V. Pickel,et al.  Ultrastructural immunocytochemical localization of the N-methyl-d-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens , 1996, Brain Research.

[54]  K. Zavitsanou,et al.  Changes in [3H]AMPA and [3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle: an autoradiographic study , 1996, Brain Research.

[55]  I. Creese,et al.  Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics , 1996, Psychopharmacology.

[56]  F. Tarazi,et al.  Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical , 1996, Harvard review of psychiatry.

[57]  F. Tarazi,et al.  Long-Term Effects of S(+)N-n-Propylnorapomorphine Compared with Typical and Atypical Antipsychotics: Differential Increases of Cerebrocortical D2-Like and Striatolimbic D4-Like Dopamine Receptors , 1997, Neuropsychopharmacology.

[58]  F. Tarazi,et al.  Regional distribution of dopamine D4 receptors in rat forebrain , 1997, Neuroreport.

[59]  P. Goldman-Rakic,et al.  Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.

[60]  J. Kebabian,et al.  Compounds selective for dopamine receptor subtypes , 1997 .

[61]  J. Bargas,et al.  Dopamine selects glutamatergic inputs to neostriatal neurons , 1997, Synapse.

[62]  I. Creese,et al.  Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment , 1997, Neuroscience.

[63]  K. Neve,et al.  Dopamine Receptors , 2008 .

[64]  D. Sibley,et al.  Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits , 1997, Synapse.

[65]  E. Malchiodi,et al.  Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. , 1997, Brain research. Molecular brain research.

[66]  R. Baldessarini.  Dopamine Receptors and Clinical Medicine , 1997 .

[67]  P. Somogyi,et al.  Cellular, Subcellular, and Subsynaptic Distribution of AMPA-Type Glutamate Receptor Subunits in the Neostriatum of the Rat , 1997, The Journal of Neuroscience.

[68]  J. Tepper,et al.  Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo , 1997, The Journal of Neuroscience.

[69]  I. Creese,et al.  Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. , 1997, The Journal of pharmacology and experimental therapeutics.

[70]  F. Tarazi,et al.  Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: Common targets for typical and atypical antepsychotic drugs , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[71]  F. Tarazi,et al.  Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors , 1998, Neuroscience.

[72]  F. Tarazi,et al.  Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors , 1998, Neuroscience Letters.

[73]  C. Tamminga,et al.  Schizophrenia and glutamatergic transmission. , 1998, Critical reviews in neurobiology.

[74]  F. Tarazi,et al.  Localization of ionotropic glutamate receptors in caudate‐putamen and nucleus accumbens septi of rat brain: Comparison of NMDA, AMPA, and kainate receptors , 1998, Synapse.

[75]  C. Cepeda,et al.  Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum , 1998, Developmental Neuroscience.

[76]  F. Tarazi,et al.  Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2- and D4-like receptors , 1998, Neuroscience.